Table 2

Antagonist binding parameters of wild-type, fragmented, and mutant muscarinic receptors coexpressed in COS-7 cells

Transfected ReceptorsHigh-Affinity BindingIC50HIC50L
% nM
Pirenzepine
 M2(1.6 μg) υ M3-tail (2.4 μg)34  ± 4114  ± 81572  ± 56
 M2 (1.6 μg) − M3-tail (2.4 μg)N.D.1462  ± 61
Tripitramine
 M3 (0.5 μg) υ M2-trunc (3.5 μg)22  ± 62.22  ± 0.29402  ± 33
 M3(0.5 μg) − M2-trunc (3.5 μg)N.D.215  ± 21
 M3-short (0.5 μg) υ M2-trunc (3.5 μg)N.D.307  ± 23
 M3-short (4 μg)N.D.255  ± 29
 M2(Asn404 → Ser) (3.3 μg) υ M3 (0.7 μg)17  ± 51.18  ± 0.22408  ± 25
 M2 (Asn404 → Ser) (0.9 μg) υ M3 (0.2 μg)2-a 21  ± 31.56  ± 0.15333  ± 29
 M2 (Asn404 → Ser) (3.3 μg) υ M3 (0.7 μg)N.D.225  ± 31
IC50 Hill Coefficient
nM
Methoctramine
 M2 (1.6 μg) υ M3-tail (2.4 μg)57.5  ± 3.910.89  ± 0.07
 M3 (0.5 μg) υ M2-trunc (3.5 μg)392  ± 260.86  ± 0.09
p-F-HHSiD
 M2 (1.6 μg) υ M3-tail (2.4 μg)318  ± 22.30.99  ± 0.05
 M3 (0.5 μg) υ M2-trunc (3.5 μg)88.4  ± 12.21.03  ± 0.25

COS-7 cells were cotransfected (υ) or separately transfected (−) with plasmid DNAs coding for M2 and M3 wild-type receptors and for different muscarinic receptor mutants. A total amount of 4 μg of DNA was transfected (the relative amount of each plasmid is given in parentheses). IC50 values were obtained in displacement curves against 200 pM [3H]NM. Competition curves were fitted to one- or two-site binding models; to determine whether the data were best fitted by a one- or two-site model, the residual sums of squares were compared by Scheffé’s F test. Data are presented as mean ± S.E. of at least four experiments, each performed in duplicate.

  • IC50H and IC50L, high and low IC50 values. N.D., not detected.

  • 2-a Supplemented with 2.9 μg of vector DNA.